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Abstract 
Preterm infants are at higher risk of adverse neurodevelopmental outcomes. Inadequate 
cerebral oxygen delivery resulting from poor cardiovascular function is likely to be a 
significant contributor to preterm brain injury. In this context, improved support of 
cardiovascular function is integral to improving preterm outcomes. Many of the treatments 
used to support preterm cardiovascular function are based on adult physiology and may not 
be appropriate for the unique physiology of the preterm infant. The preterm heart is 
structurally immature with reduced contractility and low cardiac output. However, there is 
limited evidence that inotropic support with dopamine and/or dobutamine is effective in 
preterm babies. Hypovolemia may also contribute to poor preterm cardiovascular function: 
there is evidence that capillary leakage results in considerable loss of plasma from the 
circulation of newborn preterm babies. In addition, the vasoconstrictor response to acute 
stimuli does not develop until quite late in gestation and is limited in the preterm infant. This 
may lead to inappropriate vasodilatation adding to functional hypovolemia. The first line 
treatment for hypotension in preterm infants is volume expansion with crystalloid solutions 
but this has limited efficacy in the preterm infant. More effective methods of volume 
expansion are required.  Effective support of preterm cardiovascular function requires better 
understanding of preterm cardiovascular physiology so that treatments can target mechanisms 
that are sufficiently mature to respond. 
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Among survivors of extreme preterm birth (before 28 weeks) or extremely low birthweight 
(<1000g), 10-15% develop cerebral palsy and 40-60% have some form of motor disability, a 
third of which is severe (1, 2). Cognitive impairments and learning disabilities are present in 
50% of extremely preterm infants, and there is an increased risk of attention 
deficit/hyperactivity disorder and autism (3). There is an association between low systemic 
blood flow and adverse neurodevelopmental outcome (4) suggesting that low cerebral blood 
flow and inadequate cerebral oxygen delivery contribute to high preterm disability rates. 
Very low birthweight infants have a resting cerebral blood flow (corrected for body weight) 
that is approximately half that at term and one-quarter of adult values (5, 6). This may reflect 
a lower cerebral oxygen requirement, but observations of increased cerebral oxygen 
extraction, and lower cerebral venous oxygen saturation suggest that, in some preterm 
infants, cerebral blood flow is near a critical lower limit and may even be lower than that 
required for normal oxygen delivery (5, 7, 8). In many very preterm infants cerebral tissue 
oxygenation is below the normal range for stable very preterm infants during the first days of 
life (9) supporting the hypothesis that poor cerebral tissue oxygenation contributes to 
disability. 
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In neonatal intensive care, treatments are focussed on increasing blood pressure and/or 
cardiac output to maintain cerebral oxygen delivery. This approach is based on the 
assumption that cerebral autoregulation is not fully developed in the preterm infant (10) and 
so increasing blood pressure and/or cardiac output will improve cerebral blood flow and 
oxygen delivery. Standard treatments are volume expansion with saline and inotropic 
support, usually with dopamine or dobutamine. Although some interventions produce 
increases in blood pressure and/or cardiac output in very preterm infants, almost half of the 
infants treated fail to respond (11-13). No treatments have improved long term 
neurodevelopmental outcome (11, 14, 15). The use of these treatments is based on the 
assumption that they will act in the preterm cardiovascular system in the same way that they 
do in the adult. However, there are some unique aspects of the preterm circulation that need 
to be considered. 
 
The preterm heart 
Studies in preterm animals indicate that the myocytes of the preterm heart are smaller than 
those in the term heart (16, 17). In addition, there are low numbers of binucleated myocytes, 
high numbers of proliferating cells and low numbers undergoing apoptosis compared to the 
term heart, indicating that preterm myocytes have not yet reached maturity (16, 17). Myocyte 
maturation is accelerated by glucocorticoid exposure and by stress including anaemia (16-
18). Transverse tubules are absent in early gestation and the sarcoplasmic reticulum is poorly 
developed (19). The preterm heart also has a lower the rate of calcium uptake by the 
sarcoplasmic reticulum (20). Preterm myocytes contain less contractile material and the 
contractile filaments are less well organised (19). The expression of troponin C and troponin I 
are lower in the preterm heart and this is associated with a lower maximum Ca
2+
-activated 
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force (21). Mitochondria are scattered throughout the cytoplasm rather than aligned in rows 
between the myofibrils (19). The extracellular matrix is also less developed in younger 
fetuses (17). Trying to make this immature heart work harder by administering inotropes may 
not be helpful. 
 
Furthermore, the expression of β1-adrenoceptors in the preterm heart is half of that in the term 
heart, so there are fewer β1-adrenoceptors for adrenergic inotropes to act upon (22). In the 
preterm piglet, both dopamine and dobutamine treatment resulted in smaller increases in 
contractility and arterial blood pressure compared with the term piglet (23). Cardiac output 
and cerebral blood flow in preterm piglets was approximately half that in term piglets and 
was not increased by either dopamine or dobutamine infusion (23, 24). Thus, it is not 
surprising that in preterm infants there is no clear benefit from any of the commonly used 
inotropic medications, as discussed in a recent review (25). 
 
This structural immaturity limits the pressure range over which the preterm heart is capable 
of optimal function. The preterm piglet heart lacks the ability to maintain cardiac output 
when afterload rises above 45mmHg (26), supporting the view that large increases in mean 
arterial pressure are not beneficial, and may indeed be harmful. The preterm piglet heart also 
functions poorly at low preloads, but does have significant preload reserve. This means that 
significant increases in cardiac output may be gained by increasing preload (26). These 
observations suggest that treatments to improve preterm cardiac function should ideally target 
increases in preload without excessive increases in afterload. 
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The preterm vascular system 
The preterm vascular system may also play a role in the aetiology of preterm cardiovascular 
compromise. The preterm infant is adapted for the in utero environment and not ex utero life. 
In utero it is protected from low temperatures by the mother, so there is little need for 
thermoregulatory vasoconstriction. The fetus is also protected from external threats and there 
is minimal requirement for acute redistribution of cardiac output for ‘fight-or-flight’ 
reactions. On the other hand, a predisposition to vasodilatation in the fetus would provide for 
maximal nutrient delivery to all tissues to sustain a rapid proportional growth rate that will 
not be matched at any subsequent time in life. For the fetus therefore, it is beneficial to be 
predisposed toward vasodilatation.  
In preterm fetal sheep there is a reduced vasoconstrictor response to cord occlusion and 
reduced ability to maintain peripheral vasoconstriction compared with the near term fetus 
(27). In the fetal sheep there is also reduced vascular responsiveness to adrenergic and 
peptidergic vasoconstrictors, and increased responsiveness to cholinergic vasodilator 
stimulation (28), although it is possible that these reduced responses may reflect the lower 
oxygen requirements of the fetus (29). However, these effects are also apparent postnatally 
when preterm piglets are exposed to a mild hypoxic stimulus. Endogenous catecholamine 
levels are similar in preterm and term piglets, and increase more than 20-fold following 
hypoxia in both groups (30). Term piglets respond with reductions in skin blood flow 
indicating an effective vasoconstrictor response, but peripheral blood flow is not reduced in 
preterm piglets, suggesting an inability to respond to these high levels of endogenous 
catecholamines (30). Preterm human infants also have high levels of endogenous 
catecholamines on the first day of life, equivalent to or higher than term infants (31, 32), but 
these high levels of catecholamines do not lead to higher blood pressure or systemic blood 
flow. 
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Clinical studies have confirmed that this relatively vasodilated state persists for several days 
after birth in preterm infants. There is a significant inverse relationship between skin 
microvascular flow at 24h after birth and gestational age in infants born at 24-36 weeks 
gestation; that is, the more premature the infant, the higher their microvascular flow (33). 
Similarly Wu et al (1980) observed that skin and muscle blood flow on the first 7 days after 
birth is much higher in preterm infants than in term infants (34). That study also noted that 
flow decreased with postnatal age, but most dramatically in the most premature infants. There 
was a direct correlation between gestational age and peripheral vascular resistance in both 
skin and muscle. Vascular resistance in preterm infants was less than half of that in term 
infants. Lower vascular resistance in preterm infants (27-34w) compared with term infants 
was also observed by Kidd et al (35). In very low birthweight infants an increase in skin and 
subcutaneous blood flow is thought to be due to vasodilatation in the transitional period (36). 
Vasodilatory capacity in response to local warming is significantly greater in infants born at 
24-28 weeks gestation than those born at 29-36 weeks (33). This is strong evidence that the 
preterm infant is thus predisposed toward vasodilatation. 
As the fetus approaches term and in the immediate postnatal period, there is maturation of 
both cardiac and vascular receptors, and sympathetic pathways, in preparation for the 
different cardiovascular and thermoregulatory needs of life after birth. Over the first month of 
life the sympathetic nervous system of the pig becomes more functional with a decreasing 
threshold and increasing magnitude of response to electrical stimulation of renal and lumbar 
nerves (37). The expression of β1-adrenoceptors in the heart increases two-fold between 91d 
gestation and term (115d) in the piglet (22). The density of vasoconstrictor α1-adrenoceptors 
in aortic smooth muscle is much lower in fetal sheep (125-140d) than in the ewe (38). In both 
the heart and the peripheral vascular system there are changes in the gasotransmitters 
responsible for vasodilatation, with evidence of interactions between nitric oxide, carbon 
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monoxide and hydrogen sulphide production in the preterm infant (39). These changes act to 
shift the vasoconstriction/vasodilatation balance away from vessel relaxation as term 
approaches (40). In the renin-angiotensin system the number of vasoconstrictor AT1 receptors 
in the major blood vessels increases while the number of vasodilator AT2 receptors decreases 
(41). However, premature delivery before this maturation occurs leaves the preterm neonate 
at risk of inappropriate vasodilatation. If the well-adapted preterm fetus suddenly becomes a 
preterm neonate, then the dominant state of vasodilatation is disadvantageous. Excessive 
vasodilatation will lead to reduced preload and a significant reduction in cardiac output (26). 
Higher microvascular flows in preterm infants are associated with lower mean arterial 
pressures, and there is a significant inverse correlation between microvascular flow and mean 
arterial blood pressure (42). There is also a positive relationship between microvascular flow 
and illness severity. Infants who died soon after birth were more likely to have had higher 
microvascular flow suggesting that inappropriate peripheral vasodilatation contributes to 
cardiovascular compromise (42). There are also sex differences in this vasodilatory state. 
More severe vasodilatation is seen in male infants, those who also have greater risk of 
adverse outcomes (33, 43, 44). 
 
Blood volume in the preterm infant 
Lack of an adequate blood volume may contribute to compromised preterm cardiovascular 
function. It is sometimes assumed that hypovolemia does not occur in the preterm neonate. 
This assumption is based on the observation that volume expansion with saline is ineffective 
for improving outcomes (13). There is also evidence that preterm infants have a higher % 
total body water than term infants (45). However, several factors may contribute to early 
hypovolemia in preterm infants. 
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As the pulmonary circulation opens with expansion of the lungs, the capacity of the vascular 
compartment is increased. High levels of circulating catecholamines at birth (31, 32) may 
assist the term neonate to successfully adapt to this increased capacity by increasing systemic 
vasculature resistance. However, as discussed above, the preterm neonate is less responsive 
to catecholamines (23, 30). As a result, the preterm infant may not compensate for this 
increased vascular capacity leading to a functional hypovolemia. In addition to these vascular 
factors, early loss of fluid from the vascular compartment due to excessive leakage from 
capillaries results in a significant loss of intravascular volume. The rapid loss of labelled 
albumin from the circulation coupled with early increases in haemoglobin concentration 
suggest whole plasma is lost from the circulation of the preterm infant (46, 47). Loss of 
protein from the circulation will exacerbate leakage and hypovolemia. 
Hypovolemia in preterm neonates may be very detrimental. In the preterm piglet, cerebral 
blood flow in preterm animals is about half of that in term piglets (23, 48). When blood 
volume is reduced, the term piglet adapts by increasing cerebral vascular conductance and 
maintaining cerebral blood flow. This adaptation is not seen in preterm piglets leading to 
extremely low cerebral blood flow that is likely below that required to meet oxygen delivery 
requirements (48).  
There is insufficient evidence to support the use of saline for volume expansion in preterm 
infants and there is no improvement in outcome (13). In adults, saline rapidly leaves the 
vascular system and also causes vasodilatation (49, 50). It is not surprising then that there is 
little benefit in the preterm neonate where capillaries are leaky and excessive vasodilatation is 
already present. In addition, saline distributes throughout the extracellular space – plasma and 
interstitial fluid. In the fetus and neonate, the plasma:interstitial volume ratio is decreased, 
thus decreasing the proportion that would remain in the plasma (51, 52). There is in fact some 
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evidence that saline may be harmful. In the adult, in addition to vasodilatation, saline infusion 
leads to acidosis (53, 54). In preterm piglets, saline infusion of 10-30 ml/kg does not improve 
mean arterial pressure and is associated with increased acidosis and a more negative arterial 
base excess (Fig 1). It is critical to develop more effective methods of volume expansion in 
the preterm neonate. Volume expansion with whole blood or packed red cells may, in theory, 
be more effective than saline. Red blood cells will remain within the circulation and will have 
the added benefit of increasing the oxygen carrying capacity of the blood. Beneficial effects 
of delayed cord clamping and placental transfusion support the hypothesis that volume 
expansion with blood may be more effective than saline (55). 
 
Developing New Treatments 
The first step in the development of new treatments to support preterm cardiovascular 
function is a better understanding of the aetiology of preterm cardiovascular compromise. Is 
compromised function due to incomplete cardiac maturation, poor control of the peripheral 
circulation or hypovolemia? It is likely that a combination of these will be present and that 
factors may differ between individuals. This highlights the need for improved methods to 
monitor cardiac function, preload, peripheral vascular function and blood volume. Our data in 
preterm piglets illustrate the futility of using an inappropriate treatment. If the piglet is 
hypovolemic, treatment with inotropes does not address the real problem. Dopamine and 
dobutamine have limited effectiveness for increasing mean arterial pressure or cardiac 
contractility in preterm piglets, but are even less effective when blood volume is reduced (Fig 
2). Thus, inotropes cannot restore function that is reduced due to hypovolemia. Perhaps many 
preterm babies have undetected hypovolemia and this is why their response to inotropes is so 
poor. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
When the aetiology of compromised preterm cardiovascular function is understood, it is 
critical to apply treatments that target the specific issues. Treatments that promote improved 
control of the peripheral circulation are essential. Venoconstriction may reduce functional 
hypovolemia resulting from increased vascular capacity. Preventing hypovolemia will 
harness the significant preload reserve of the preterm heart and increase cardiac output 
without inducing excessive afterload. Effective volume expansion may also lead to improved 
cardiac function through increased preload, and improve outcomes. Treatments must target 
the unique preterm physiology and not simply assume that the preterm physiology and 
treatment response is the same as adults, or even older children.  
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Figure Legends 
Figure 1: Mean arterial pressure (MAP), arterial pH and base excess (ABE) in untreated 
(n=3) and saline infused (n=4) preterm piglets on the first day of life at 97d gestation 
(equivalent to approximately 27 human weeks, piglet term is 115d). All piglets had mean 
arterial pressure <27mmHg at baseline. Saline treated piglets received three infusions of 10 
ml/kg of 0.9% saline over a total of 3h following baseline measurements. All measurements 
were repeated 4 hours after baseline. At 4 hours, MAP (Student’s t test, P=0.024), pH and 
ABE (arterial base excess) (both Mann-Whitney U test, P=0.034) were significantly lower in 
saline treated preterm piglets than in untreated piglets. * indicates significant difference 
between untreated and saline treated piglets (P<0.05).  
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Figure 2: Mean arterial pressure and cardiac contractility in term (115d) and preterm (97d) 
piglets during baseline, low dose (10µg/kg/min) and high dose (20µg/kg/min) dopamine or 
dobutamine treatment and in the presence of normovolemia and hypovolemia. N = 6-10 
piglets per group at each data point. Inotropes have minimal effects in normovolemic preterm 
piglets but are less effective when preterm piglets are hypovolemic. In the presence of 
hypovolemia, inotropic treatment is less likely to lead to normal function than inotropic 
treatment in the presence of normovolemia. * indicates a significant difference between 
normovolemia and hypovolemia conditions at a given dose (P<0.05).  
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